Lynch & Associates/In’s Merck & Co Inc Position
Does Lynch & Associates/In own Merck & Co Inc (MRK)? Yes — 93.4K shares worth $11M (+2.11% of its 13F portfolio) as of Q1 2026, up from 93.0K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
93.4K
% of Portfolio
+2.11%
Quarters Held
30
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 93.4K | $11M | +2.11% |
| Q4 2025 | 93.0K | $10M | +1.85% |
| Q3 2025 | 90.4K | $8M | +1.46% |
| Q2 2025 | 89.2K | $7M | +1.42% |
| Q1 2025 | 90.3K | $8M | +1.75% |
| Q4 2024 | 90.6K | $9M | +1.96% |
| Q3 2024 | 92.7K | $11M | +2.23% |
| Q2 2024 | 92.9K | $12M | +2.59% |
| Q1 2024 | 90.2K | $12M | +2.75% |
| Q4 2023 | 94.6K | $10M | +2.51% |
| Q3 2023 | 101.3K | $11M | +2.94% |
| Q2 2023 | 99.5K | $11,480 | +2.94% |
| Q1 2023 | 99.8K | $10,620 | +2.79% |
| Q4 2022 | 101.3K | $11,243 | +2.94% |
| Q3 2022 | 105.0K | $9M | +2.64% |
| Q2 2022 | 104.3K | $10M | +2.59% |
| Q1 2022 | 105.2K | $9M | +2.09% |
| Q4 2021 | 105.1K | $8M | +1.90% |
| Q3 2021 | 102.2K | $8M | +1.99% |
| Q2 2021 | 99.7K | $8M | +1.99% |
| Q1 2021 | 100.9K | $8M | +2.10% |
| Q4 2020 | 103.2K | $8M | +2.30% |
| Q3 2020 | 102.3K | $8M | +2.54% |
| Q2 2020 | 102.8K | $8M | +2.57% |
| Q1 2020 | 104.9K | $8M | +2.97% |
| Q4 2019 | 104.9K | $10M | +2.74% |
| Q3 2019 | 99.8K | $8M | +2.57% |
| Q2 2019 | 99.1K | $8M | +2.70% |
| Q1 2019 | 100.3K | $8M | +2.77% |
| Q4 2018 | 99.0K | $8M | +2.82% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lynch & Associates/In’s full portfolio or all institutional holders of MRK.